Effect of hydroxyapatite and β-tricalcium phosphate nanoparticles on promonocytic U937 cells

Journal of Biomedical Nanotechnology

Volumn 6, Issue 2, 2010, Pages 158-165

  Sylvie, Jeanne ^a   Sylvie, Tricot Doleux ^a   Pascal, Pellen Mussi ^a   Fabienne, Perez ^a   Hassane, Oudadesse ^a   Guy, Cathelineau ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Bioceramics; Bone substitute; Cytocompatibility; Macrophage; Nanoparticles

Indexed keywords

ANNEXINS; APOPTOSIS; BIOLOGICAL EFFECTS; BONE SUBSTITUTES; CELL CYCLE; CYCLE TESTS; CYTOCOMPATIBILITY; IMPLANT FAILURES; IMPLANTED MATERIALS; IN-VITRO; INFLAMMATORY RESPONSE; MICRO-PARTICLES; NANOMETER-SIZED PARTICLES; SULFORHODAMINE B; TRI-CALCIUM PHOSPHATES; U937 CELL;

BIOCERAMICS; BONE; CELL DEATH; CONFOCAL MICROSCOPY; FAILURE ANALYSIS; FLOW CYTOMETRY; HYDROXYAPATITE; MACROPHAGES; VANADIUM;

NANOPARTICLES;

ANNEXIN; BETA2 INTEGRIN; CALCIUM PHOSPHATE; CD18 ANTIGEN; CD69 ANTIGEN; HYDROXYAPATITE; INTERCELLULAR ADHESION MOLECULE 1; NANOPARTICLE; PHOSPHATIDYLSERINE; SULFORHODAMINE B;

APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; CELL ACTIVATION; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CELL STRAIN U937; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MACROPHAGE; MONOCYTE MACROPHAGE PRECURSOR CELL; PARTICLE SIZE; PROTEIN EXPRESSION;

ANALYSIS OF VARIANCE; ANTIGENS, CD; APOPTOSIS; BONE SUBSTITUTES; CALCIUM PHOSPHATES; CELL CYCLE; CYTOTOXICITY TESTS, IMMUNOLOGIC; DURAPATITE; FLOW CYTOMETRY; HUMANS; MICROSCOPY, CONFOCAL; NANOPARTICLES; PHENOTYPE; RHODAMINES; U937 CELLS;

EID: 77955458133     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2010.1109     Document Type: Article

References (44)

1. O. Gauthier, E. Goyenvalle, J. M. Bouler, J. Guicheux, P. Pilet, P. Weiss, and G. Daculsi, Macroporous biphasic calcium phosphate ceramics versus injectable bone substitute: A comparative study 3 and 8 weeks after implantation in rabbit bone. J. Mater. Sci. Mater. Med. 12, 385 (2001).
2. A. Grandjean-Laquerriere, P. Laquerriere, M. Guenounou, D. Laurent-Maquin, and T. M. Phillips, Importance of the surface area ratio on cytokines production by human monocytes in vitro induced by various hydroxyapatite particles. Biomaterials 26, 2361 (2005).
3. P. Laquerriere, A. Grandjean-Laquerriere, E. Jallot, G. Balossier, P. Frayssinet, and M. Guenounou, Importance of hydroxyapatite particles characteristics on cytokines production by human monocytes in vitro. Biomaterials 24, 2739 (2003).
4. T. J. Webster, C. Ergun, R. H. Doremus, R. W. Siegel, and R. Bizios, Enhanced functions of osteoblasts on nanophase ceramics. Biomaterials 21, 1803 (2000).
5. U. Mukesh, V. Kulkarni, R. Tushar, and R. S. Murthy, Methotrexate loaded self stabilized calcium phosphate nanoparticles: A novel inorganic carrier for intracellular drug delivery. J. Biomed. Nanotechnol. 5, 99 (2009).
6. I. Papageorgiou, C. Brown, R. Schins, S. Singh, R. Newson, S. Davis, J. Fisher, E. Ingham, and C. P. Case, The effect of nano- and micron-sized particles of cobalt-chromium alloy on human fibroblasts in vitro. Biomaterials 28, 2946 (2007).
7. E. Yagil-Kelmer, P. Kazmier, M. N. Rahaman, B. S. Bal, R. K. Tessman, and D. M. Estes, Comparison of the response of primary human blood monocytes and the U937 human monocytic cell line to two different sizes of alumina ceramic particles. J. Orthop. Res. 22, 832 (2004).
8. T. R. Green, J. Fisher, M. Stone, B. M. Wroblewski, and E. Ingham, Polyethylene particles of a 'critical size' are necessary for the induction of cytokines by macrophages in vitro. Biomaterials 19, 2297 (1998).
9. J. W. Larrick, D. G. Fischer, S. J. Anderson, and H. S. Koren, Characterization of a human macrophage-like cell line stimulated in vitro: A model of macrophage functions. J. Immunol. 125, 6 (1980).
10. J. Prieto, A. Eklund, and M. Patarroyo, Regulated expression of integrins and other adhesion molecules during differentiation of monocytes into macrophages. Cell. Immunol. 156, 191 (1994).
11. Z. Shi, X. Huang, Y. Cai, R. Tang, and D. Yang, Size effect of hydroxyapatite nanoparticles on proliferation and apoptosis of osteoblast-like cells. Acta Biomater. 5, 338 (2009).
12. X. Chen, C. Deng, S. Tang, and M. Zhang, Mitochondria-dependent apoptosis induced by nanoscale hydroxyapatite in human gastric cancer SGC-7901 cells. Biol. Pharm. Bull. 30, 128 (2007).
13. Z. S. Liu, S. L. Tang, and Z. L. Ai, Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human hepatoma BEL-7402 cells. World J. Gastroenterol. 9, 1968 (2003).
14. H. Liu, H. Yazici, C. Ergun, T. J. Webster, and H. Bermek, An in vitro evaluation of the Ca/P ratio for the cytocompatibility of nano-to-micron particulate calcium phosphates for bone regeneration. Acta Biomater. A, 1472 (2008).
15. F. Chellat, A. Grandjean-Laquerriere, R. Le Naour, J. Fernandes, L. Yahia, M. Guenounou, and D. Laurent-Maquin, Metalloproteinase and cytokine production by THP-1 macrophages following exposure to chitosan-DNA nanoparticles. Biomaterials 26, 961 (2005).
16. J. Curtis, M. Greenberg, J. Kester, S. Phillips, and G. Krieger, Nanotechnology and nanotoxicology: A primer for clinicians. Toxicol. Rev. 25, 245 (2006).
17. P. S. Melo, M. M. De Azevedo, L. Frungillo, M. C. Anazetti, P. D. Marcato, and N. Duran, Nanocytotoxicity: Violacein and violacein-loaded poly (D, L-lactide-co-glycolide) nanoparticles acting on human leukemic cells. J. Biomed. Nanotechnol. 5, 192 (2009).
18. G. Oberdorster, E. Oberdorster, and J. Oberdorster, Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113, 823 (2005).
19. M. R. Wilson, J. H. Lightbody, K. Donaldson, J. Sales, and V. Stone, Interactions between ultrafine particles and transition metals in vivo and in vitro. Toxicol. Appl. Pharmacol. 184, 172 (2002).
20. H. Yang, Q. Wu, M. Tang, L. Kong, and Z. Lu, Cell membrane injury induced by silica nanoparticles in mouse macrophage. J. Biomed. Nanotechnol. 5, 528 (2009).
21. M. A. Germain, A. Hatton, S. Williams, J. B. Matthews, M. H. Stone, J. Fisher, and E. Ingham, Comparison of the cytotoxicity of clinically relevant cobalt-chromium and alumina ceramic wear particles in vitro. Biomaterials 24, 469 (2003).
22. C. F. Vogel, E. Sciullo, P. Wong, P. Kuzmicky, N. Kado, and F. Matsumura, Induction of proinflammatory cytokines and C-reactive pro- tein in human macrophage cell line U937 exposed to air pollution particulates. Environ. Health Perspect 113, 1536 (2005).
23. K. Donaldson and V. Stone, Current hypotheses on the mechanisms of toxicity of ultrafine particles. Ann. Ist Super Sanita 39, 405 (2003).
24. K. Donaldson, V. Stone, C. L. Tran, W. Kreyling, and P. J. Borm, Nanotoxicology. Occup. Environ. Med. 61, 727 (2004).
25. N. Lewinski, V. Colvin, and R. Drezek, Cytotoxicity of nanoparticles. Small 4, 26 (2008).
26. M. Lucarelli, A. M. Gatti, G. Savarino, P. Quattroni, L. Martinelli, E. Monari, and D. Boraschi, Innate defence functions of macrophages can be biased by nano-sized ceramic and metallic particles. Eur. Cytokine Netw. 15, 339 (2004).
27. M. Geppert, M. Hohnholt, L. Gaetjen, I. Grunwald, M. Baumer, and R. Dringen, Accumulation of iron oxide nanoparticles by cultured brain astrocytes. J. Biomed. Nanotechnol. 5, 285 (2009).
28. A. Yamamoto, R. Honma, M. Sumita, and T. Hanawa, Cytotoxicity evaluation of ceramic particles of different sizes and shapes. J. Biomed. Mater. Res. A 68, 244 (2004).
29. L. G. Gutwein and T. J. Webster, Increased viable osteoblast density in the presence of nanophase compared to conventional alumina and titania particles. Biomaterials 25, 4175 (2004).
30. T. J. Webster, R. W. Siegel, and R. Bizios, Nanoceramic surface roughness enhances osteoblast and osteoclast functions for improved orthopaedic/dental implant efficacy. Scr. Mater. 44, 1639 (2001).
31. S. Bhattacharyya, S. G. Kumbar, Y. M. Khan, L. S. Nair, A. Singh, N. R. Krogman, P. W. Brown, H. R. Allcock, and C. T. Laurencin, Biodegradable polyphosphazene-nanohydroxyapatite composite nanofibers: Scaffolds for bone tissue engineering. J. Biomed. Nanotechnol. 5, 69 (2009).
32. N. R. Webster, C. Ergun, R. H. Doremus, R. W Siegel, and R. Bizios, Enhanced osteoclast-like cell functions on nanophase ceramics. Biomaterials 22, 1327 (2001).
33. W. Sun, C. Chu, J. Wang, and H. Zhao, Comparison of periodontal ligament cells responses to dense and nanophase hydroxyapatite. J. Mater. Sci. Mater. Med. 18, 677 (2007).
34. G. Balasundaram, M. Sato, and T. J. Webster, Using hydroxyapatite nanoparticles and decreased crystallinity to promote osteoblast adhesion similar to functionalizing with RGD. Biomaterials 27, 2798 (2006).
35. G. Orsini, M. Piattelli, A. Scarano, G. Petrone, J. Kenealy, A. Piattelli, and S. Caputi, Randomized, controlled histologic and histomorphometric evaluation of implants with nanometer-scale calcium phosphate added to the dual acid-etched surface in the human posterior maxilla. J. Periodontal. 78, 209 (2007).
36. X. Guo, J. E. Gough, P. Xiao, J. Liu, and Z. Shen, Fabrication of nanostructured hydroxyapatite and analysis of human osteoblastic cellular response. J. Biomed. Mater. Res. A 82, 1022 (2007).
37. A. Eidukaite and V. Tamosiunas, Endometrial and peritoneal macrophages: Expression of activation and adhesion molecules. Am. J. Reprod. Immunol. 52, 113 (2004).
38. D. Sancho, M. Gomez, and F. Sanchez-Madrid, CD69 is an immunoregulatory molecule induced following activation. Trends Immunol. 26, 136 (2005).
39. L. Kikuchi, J. Y. Park, C. Victor, and J. E. Davies, Platelet interactions with calcium-phosphate-coated surfaces. Biomaterials 26, 5285 (2005).
40. W. Moller, D. M. Brown, W. G. Kreyling, and V. Stone, Ultrafine particles cause cytoskeletal dysfunctions in macrophages: Role of intracellular calcium. Part Fibre Toxicol. 2, 7 (2005).
41. O. Gauthier, J. M. Bouler, P. Weiss, J. Bosco, E. Aguado, and G. Daculsi, Short-term effects of mineral particle sizes on cellular degradation activity after implantation of injectable calcium phosphate biomaterials and the consequences for bone substitution. Bone 25, 71S (1999).
42. F. Chellat, Y. Merhi, A. Moreau, and L. Yahia, Therapeutic potential of nanoparticulate systems for macrophage targeting. Biomaterials 26, 7260 (2005).
43. M. Riedel, B. Muller, and E. Wintermantel, Protein adsorption and monocyte activation on germanium nanopyramids, Biomaterials 22, 2307 (2001).
44. E. M. Greenfield, Y. Bi, A. A. Ragab, V. M. Goldberg, J. L. Nalepka, and J. M. Seabold, Does endotoxin contribute to aseptic loosening of orthopedic implants? J. Biomed. Mater. Res. B Appl. Biomater. 72, 179 (2005).